+1. Not bad indeed. Look at % revenue growth... demonstrates (local market) revenue generation doing well.
- Q4 FY20 Operating Revenue (up 31.4% from Q4 FY19) & (up 40.8% from Q3 FY20)
- Q4 FY20 Total Revenue (up 41.0% v Q4 FY19) & (up 99.8% vs Q3 FY20)
- FY20 Operating Revenue (up 17.0% from FY19)
- FY20 Total Revenue (up 20.8% from FY19)
Operating Costs Q4 FY20 $1.095m improved from Q3 FY20 $2.668m from better cost management, granted yes, a significant amount of it is boosted by government grants and incentives. This is operating steadily but agree... would love to see international revenues start contributing for this to fly. $MDR reporting Asia being on track to deliver revenue next quarter is promising. Keep watching.
- Forums
- ASX - By Stock
- Ann: MedAdvisor June 2020 Quarterly Activities Report
+1. Not bad indeed. Look at % revenue growth... demonstrates...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDR (ASX) to my watchlist
|
|||||
Last
54.0¢ |
Change
-0.010(1.82%) |
Mkt cap ! $297.2M |
Open | High | Low | Value | Volume |
53.5¢ | 54.5¢ | 51.0¢ | $105.8K | 202.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3780 | 52.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.0¢ | 9069 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1904 | 0.525 |
1 | 1346 | 0.520 |
1 | 43478 | 0.510 |
2 | 9500 | 0.505 |
6 | 125001 | 0.500 |
Price($) | Vol. | No. |
---|---|---|
0.540 | 9069 | 1 |
0.550 | 21685 | 1 |
0.560 | 4000 | 1 |
0.565 | 2500 | 1 |
0.570 | 28328 | 2 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |